Regression of atherosclerosis.

Por Leiter, L A
Publicado em 1991

Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.

Por Sarabia, V, Lam, L, Burdett, E, Leiter, L A, Klip, A
Publicado em 1992

Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management

Por Aschner, P, Horton, E, Leiter, L A, Munro, N, Skyler, J S
Publicado em 2010

Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

Por Ng, D S, Leiter, L A, Vezina, C, Connelly, P W, Hegele, R A
Publicado em 1994

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials

Por Leiter, L. A., Müller‐Wieland, D., Baccara‐Dinet, M. T., Letierce, A., Samuel, R., Cariou, B.
Publicado no Diabet Med (2017)

Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.

Por Ogilvie, R I, Burgess, E D, Cusson, J R, Feldman, R D, Leiter, L A, Myers, M G
Publicado em 1993

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial (...

Por Aroda, V. R., Bailey, T. S., Cariou, B., Kumar, S., Leiter, L. A., Raskin, P., Zacho, J., Andersen, T. H., Philis‐Tsimikas, A.
Publicado no Diabetes Obes Metab (2016)

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Por Masmiquel, L., Leiter, L. A., Vidal, J., Bain, S., Petrie, J., Franek, E., Raz, I., Comlekci, A., Jacob, S., van Gaal, L., Baeres, F. M. M., Marso, S. P., Eriksson, M.
Publicado no Cardiovasc Diabetol (2016)

The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes

Por Jenkins, D. J. A., Srichaikul, K., Kendall, C. W. C., Sievenpiper, J. L., Abdulnour, S., Mirrahimi, A., Meneses, C., Nishi, S., He, X., Lee, S., So, Y. T., Esfahani, A., Mitchell, S., Parker, T. L., Vidgen, E., Josse, R. G., Leiter, L. A.
Publicado em 2010

1999 Canadian recommendations for the management of hypertension

Por Feldman, R D, Campbell, N, Larochelle, P, Bolli, P, Burgess, E D, Carruthers, S G, Floras, J S, Haynes, R B, Honos, G, Leenen, F H, Leiter, L A, Logan, A G, Myers, M G, Spence, J D, Zarnke, K B
Publicado em 1999

Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials

Por Chiu, S, Sievenpiper, J L, de Souza, R J, Cozma, A I, Mirrahimi, A, Carleton, A J, Ha, V, Di Buono, M, Jenkins, A L, Leiter, L A, Wolever, T M S, Don-Wauchope, A C, Beyene, J, Kendall, C W C, Jenkins, D J A
Publicado em 2014